CRG LP is a global healthcare investment firm specializing in medical devices, bio-pharmaceuticals, diagnostics, and healthcare IT. The firm provides growth capital through both debt and equity structures, focusing on minimizing dilution for its partners. CRG's investments span various stages, including debt financing, private equity, and post-IPO debt, supporting companies worldwide in their growth and innovation efforts.
Notable portfolio companies include Dynavax Technologies, Earlens, Harmony Biosciences, and Synergy Pharmaceuticals. CRG's investment philosophy emphasizes collaborative partnerships and strong value-added support to ensure the success of its investments. The firm targets consistent and attractive returns for its limited partners while fostering innovation and growth in the healthcare sector.
CRG - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments35
Current Portfolio Count23
Total Portfolio Exits6
Top Investment Stages
Debt Financing16 (51.6%)
Post Ipo Debt7 (22.6%)
Private Equity3 (9.7%)
Series Unknown3 (9.7%)
Series C2 (6.5%)
Stage Mix
Debt Financing 52%Post Ipo Debt 23%Private Equity 10%Series Unknown 10%Series C 6%
Concentration shown as share of disclosed investments by stage.
CRG - Classification
- Also Known As
- CRG LP
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
Show 2 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- SIC
- 6000Depository Institutions